Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Clears Topical Treatment for ‘Butterfly Children’

The novel delivery strategy is already being considered for the treatment of other rare skin conditions.

Krystal
Krystal

Dystrophic epidermolysis bullosa is a rare inherited disease that causes fragile skin. People with the condition, known as "butterfly children," suffer from chronic blistering wounds all over their bodies and even in their throats and eyes. According to a recent MIT Technology News article, the FDA just approved the first gene therapy to treat the condition that is applied externally to the body. 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging